e-learning
resources
Munich 2014
Sunday, 07.09.2014
Physical activity, exercise and physiotherapy in patients with COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?
G. L. Moreira, N. A. Hernandes, T. Paes, K. C. Furlanetto, T. Sant'Anna, L. Donaria, F. Pitta (Londrina, Brazil)
Source:
International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Session:
Physical activity, exercise and physiotherapy in patients with COPD
Session type:
Thematic Poster Session
Number:
1285
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. L. Moreira, N. A. Hernandes, T. Paes, K. C. Furlanetto, T. Sant'Anna, L. Donaria, F. Pitta (Londrina, Brazil). GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?. Eur Respir J 2014; 44: Suppl. 58, 1285
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
What should be part of a comprehensive assessment of COPD?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Efficacy of early COPD diagnosis and intervention system
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Are there any differences between Tunisian and European COPD phenotypes?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Is an EXACT score applicable Japanese patients with COPD?
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Comparison of modified medical research council scale and COPD assessment test in subjects with COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept